Target intelligence / Profile preview

Immunoglobulin lambda variable 2-14 (IGLV2-14)

Target
IGLV2-14
Molecular classification
Immunoglobulin variable domain, Immunoglobulin light chain variable region, Gene segment of adaptive immune system
01

Overview

Immunoglobulin lambda variable 2-14 (IGLV2-14) encodes the variable domain of the lambda light chain in human immunoglobulins. This region contributes to the formation of the antigen-binding site, enabling antibodies to recognize and bind to a diverse range of antigens. It is produced by B lymphocytes and is essential for adaptive immune responses. The variable domains of immunoglobulins are created through genetic recombination, generating antibody diversity. Abnormalities in immunoglobulin gene rearrangements can be associated with certain cancers, particularly of lymphoid cells, and autoimmune conditions. However, IGLV2-14 itself is not used as a direct drug target, but the antibodies that include it may be studied or engineered for therapeutic or diagnostic purposes.

Other names
Ig lambda chain V-II region NIG-84Ig lambda chain V-II region TOGIg lambda chain V-II region VILIGLV214V1-4
02

Mechanism of action

Not applicable; this is a gene segment/intrinsic antibody domain, not a target for pharmacological intervention.

03

Biological functions

Antigen bindingImmune responseComponent of B-cell receptorFormation of antibody diversity
04

Disease associations

Cancer (via abnormal immunoglobulin gene rearrangements, e.g., in lymphomas or multiple myeloma)Immunoglobulinopathies (as a marker in research)Autoimmune disease (as a marker in research)

Beyond the preview

Go deeper on Immunoglobulin lambda variable 2-14 (IGLV2-14).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable 2-14 (IGLV2-14).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call